Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment

NCT07102030 is registered in ClinicalTrials.gov with Region Stockholm as lead sponsor.

NCT NCT07102030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07102030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment
Lead sponsor
Region Stockholm
Phase
Observational
Overall status
Recruiting
Start date
February 15, 2015
Completion date
December 31, 2032
Enrollment
900 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus